Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


PDA: “An absurdity” to report locums for negotiating higher rates

It would be an “absurdity” and “abuse of the regulatory system” to report locums to the GPhC for negotiating higher hourly rates, the Pharmacists’ Defence Association has said.

A statement issued by  General Pharmaceutical Council (GPhC) chief executive Duncan Rudkin earlier this month (March 19) warned pharmacy professionals against “profiteering to take selfish advantage” of the COVID-19 outbreak, either with “prices of shortage products or locum rates”.

Doing so “risks bringing the profession into disrepute at a time when public confidence generally is so fragile and so important”, Mr Rudkin said.

In a response published yesterday (March 30), the PDA said it  “understands the sentiments” of the regulator as vastly inflated locum rates during the pandemic could “undermine wider public confidence in the profession”. However, the GPhC has “no other legitimate regulatory interest in the commercial rates agreed between locums and their clients”, the organisation added.

“To refer a locum to the GPhC for simply negotiating a higher hourly rate would be an absurdity and an abuse of the regulatory system,” The PDA said.

Community pharmacy locum rates must be “individually negotiated” between the locum and the client or through a locum agency, something that is an “important element of a free market arrangement”, the PDA said.

“It is unlawful for employers acting together, or by conspiring with a locum agency, to seek to manipulate market rates and inhibit free market conditions,” it  added.

The Competition and Markets Authority (CMA) has “extensive enforcement powers” when it comes to any individual or comapny that behaves in this way, the PDA said.

Anti-competition law

The PDA highlighted that the same anti-competition rules that apply to  businesses also apply to locum pharmacists too

Although negotiating rates is part of the supply and demand model in a free market economy, locums who “discuss how they might seek to fix a minimum market rate”, boycott pharmacies or “are seen to encourage others to take advantage of the pandemic situation” risk CMA sanctions, the PDA said.

The organisation said it will defend locum members who “act responsibly” against regulatory or other complaints

Have you worked locum shifts during the COVID-19 outbreak?

Related Content


Pharmacy Manager
Newquay, Cornwall
£ Competitive

Apply Now
Latest News & Analysis
See All



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts